On Invalid Date, Biote (NASDAQ: BTMD) reported Q1 2023 earnings per share (EPS) of -$0.39, up 104.09% year over year. Total Biote earnings for the quarter were -$6.81 million. In the same quarter last year, Biote's earnings per share (EPS) was $9.54.
As of Q2 2023, Biote's earnings has grown year over year. Biote's earnings in the past year totalled -$7.77 million.
What was BTMD's revenue last quarter?
On Invalid Date, Biote (NASDAQ: BTMD) reported Q1 2023 revenue of $44.84 million up 20.73% year over year. In the same quarter last year, Biote's revenue was $37.14 million.
What was BTMD's revenue growth in the past year?
As of Q2 2023, Biote's revenue has grown 19.08% year over year. This is 11.6 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 7.48%. Biote's revenue in the past year totalled $172.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.